Angiotensin Converting Enzyme Inhibitors: The End of End-Stage Renal Disease?
- 15 September 1989
- journal article
- editorial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 111 (6) , 451-453
- https://doi.org/10.7326/0003-4819-111-6-451
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathyJournal Of Hypertension, 1988
- Effect of Transplantation on the Medicare End-Stage Renal Disease ProgramNew England Journal of Medicine, 1988
- Preventing the progression of human renal disease: Have rational therapeutic principles emerged?Kidney International, 1988
- Converting enzyme inhibition and progressive glomerulosclerosis in the ratKidney International, 1987
- Verapamil protects against progression of experimental chronic renal failureKidney International, 1987
- Disparate Effects of Angiotensin Converting Enzyme Inhibitor and Calcium Blocker Treatment on the Preservation of Renal Structure and Function Following Subtotal Nephrectomy or Streptozotocin-Induced Diabetes in the RatJournal of Cardiovascular Pharmacology, 1987
- Nephrotoxic serum nephritis with hypertension: Amelioration by antihypertensive therapyKidney International, 1985
- EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHYThe Lancet, 1983
- Medical Management of Renal SclerodermaNew England Journal of Medicine, 1978
- Effects of Treatment on Morbidity in HypertensionJAMA, 1967